Cohort Profile:The Haematological Malignancy Research Network (HMRN); a UK population-based patient cohort

• Smith, Alexandra https://orcid.org/0000-0002-1111-966X
• Howell, Debra https://orcid.org/0000-0002-7521-7402
• Crouch, Simon https://orcid.org/0000-0002-3026-2859
• Painter, Dan https://orcid.org/0000-0002-3936-7569
• Blase, John (jsb503@york.ac.uk)
• Wang, Han-I https://orcid.org/0000-0002-3521-993X
• Hewison, Ann https://orcid.org/0000-0003-4196-0270
• Bagguley, Timothy https://orcid.org/0000-0002-6150-3467
• Appleton, Simon
• Kinsey, Sally
• Burton, Cathy
• Patmore, Russell
• Roman, Eve https://orcid.org/0000-0001-7603-3704

© The Author(s) 2018 Funding Information: specifically established in the UK in 2004 to address the needs outlined above by producing ‘real-time’, robust generalizable data on haematological malignancies to inform contemporary clinical practice and research: locally, nationally and internationally.28 With core support from Bloodwise [www.bloodwise.org.uk], formerly Leukaemia and Lymphoma Research, HMRN is the result of a unique collaboration between university researchers, National Health Service (NHS) clinicians and patients/carers. Funding Information: This work was supported by Bloodwise [grant number 15037], and has ethics approval (REC 04/01/1205/69) from Leeds West Research Ethics Committee, R&D approval from each NHS Trust and exemption from Section 251 of the Health & Social Care Act (PIAG 1–05(h)/2007).

• Accepted: 6 March 2018
• Published (online): 2 April 2018
• Published: June 2018

• http://www.scopus.com/inward/record.url?...
• https://academic.oup.com/ije/advance-art...